Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: A review of the literature

HIV Medicine

Volumn 13, Issue 6, 2012, Pages 319-332

  Shadyab, A H ^a   Crum Cianflone, N F ^a,b  

^a SAN DIEGO STATE UNIVERSITY   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

Author keywords

AIDS; Epidemiology; HIV; Management; Methicillin resistant Staphylococcus aureus (MRSA); Prevention; Recurrence; Review; Risk factors; Sskin and soft tissue infections

Indexed keywords

ANTIRETROVIRUS AGENT; CEFTAROLINE; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; HEXACHLOROPHENE; ILLICIT DRUG; LINEZOLID; MINOCYCLINE; PANTON VALENTINE LEUKOCIDIN; PSEUDOMONIC ACID; RIFAMPICIN; TELAVANCIN; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; COMORBIDITY; DRUG USE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INFECTION RISK; MEDLINE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SEXUAL BEHAVIOR; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; SYSTEMATIC REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG USERS; FEMALE; HIV-1; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; UNITED STATES;

EID: 84861798854     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00978.x     Document Type: Review

References (67)

1. Klevens RM, Morrison MA, Nale J etal. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763-1771.
2. Moran GJ, Krishnadasan A, Gorwitz RJ etal. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-674.
3. Kluytmans J, Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505-520.
4. Popovich KJ, Weinstein RA, Aroutcheva A etal. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 2010; 50: 979-987.
5. Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS 2007; 18: 521-526.
6. Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 33: 1412-1416.
7. Davis KA, Stewart JJ, Crouch HK etal. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39: 776-782.
8. Ellis MW, Hospenthal DR, Dooley DP etal. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39: 971-979.
9. Shet A, Mathema B, Mediavilla JR etal. Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1. J Infect Dis 2009; 200: 88-93.
10. Szumowski JD, Wener KM, Gold HS etal. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clin Infect Dis 2009; 49: 118-121.
11. Sissolak D, Geusau A, Heinze G etal. Risk factors for nasal carriage of Staphylococcus aureus in infectious disease patients, including patients infected with HIV, and molecular typing of colonizing strains. Eur J Clin Microbiol Infect Dis 2002; 21: 88-96.
12. McDonald LC, Lauderdale TS, Lo HJ etal. Colonization of HIV-infected outpatients in Taiwan with methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Int J STD AIDS 2003; 14: 473-477.
13. Cenizal MJ, Hardy RD, Anderson M etal. Prevalence of and risk factors for methicillin-resistant nasal colonization in HIV-infected ambulatory patients. J Acquir Immune Defic Syndr 2008; 48: 567-571.
14. Villacian JS, Barkham T, Earnest A etal. Prevalence of and risk factors for nasal colonization with Staphylococcus aureus among human immunodeficiency virus-positive outpatients in Singapore. Infect Control Hosp Epidemiol 2004; 25: 438-440.
15. Antoniou T, Devlin R, Gough K etal. Prevalence of community-associated methicillin-resistant Staphylococcus aureus colonization in men who have sex with men. Int J STD AIDS 2009; 20: 180-183.
16. Seybold U, Kourbatova V, Johnson JG etal. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006; 42: 647-656.
17. Crum-Cianflone NF, Shadyab AH, Weintrob A etal. Association of methicillin-resistant Staphylococcus aureus (MRSA) colonization with high-risk sexual behaviors in HIV-infected persons. Medicine (Baltimore) 2011; 90: 379-389.
18. Peters PJ, Brooks JT, Limbago B etal. Methicillin-resistant Staphylococcus aureus colonization in HIV-infected outpatients is common and detection is enhanced by groin culture. Epidemiol Infect 2010 [Epub ahead of print].
19. Gorwitz RJ, Kruszon-Moran D, McAllister SK etal. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197: 1226-1234.
20. Ramsetty SK, Stuart LL, Blake RT etal. Risk for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection. HIV Med 2010; 11: 389-394.
21. Chacko J, Kuruvila M, Bhat GK. Factors affecting the nasal carriage of methicillin-resistant Staphylococcus aureus in human immunodeficiency virus-infected patients. Indian J Med Microbiol 2009; 27: 146-148.
22. Skiest D, Brown K, Hester J etal. Community onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med 2006; 7: 361-368.
23. Tumbarello M, de Gaetano Donati K, Tacconelli E etal. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002; 50: 375-382.
24. Lee NE, Taylor MM, Bancroft E etal. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005; 40: 1529-1534.
25. Mathews WC, Caperna JC, Barber RE etal. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005; 40: 155-160.
26. Anderson EJ, Hawkins C, Bolon MK etal. A series of skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. J Acquir Immune Defic Syndr 2006; 41: 125-127.
27. Szumowski JD, Cohen DE, Kanaya F etal. Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother 2007; 51: 423-428.
28. Drapeau C, Angeletti C, Festa A etal. Role of previous hospitalizations in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control study. BMC Infect Dis 2007; 7: 36.
29. Shastry L, Rahimian J, Lascher S. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City. Arch Intern Med 2007; 167: 854-857.
30. Sztramko R, Katz K, Antoniou T etal. Community-associated methicillin-resistant Staphylococcus aureus infections in men who have sex with men: a case series. Can J Infect Dis Med Microbiol 2007; 18: 257-261.
31. Burkey MD, Wilson LE, Moore RD etal. The incidence of and risk factors for MRSA bacteremia in an HIV-infected cohort in the HAART era. HIV Med 2008; 9: 858-862.
32. Diep BA, Chambers HF, Graber CJ etal. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148: 249-257.
33. Graber CJ, Jacobson MA, Perdreau-Remington F etal. Recurrence of skin and soft-tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr 2008; 49: 231-233.
34. Trinh TT, Short WR, Mermel LA. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients. J Int Assoc Physicians AIDS Care (Chic) 2009; 8: 176-180.
35. Crum-Cianflone NF, Weekes J, Bavaro M. Recurrent community-associated methicillin-resistant Staphylococcus aureus infections among HIV-infected persons: incidence and risk factors. AIDS Patient Care STDS 2009; 23: 499-502.
36. Krucke GW, Grimes DE, Grimes RM etal. Antibiotic resistance in the Staphylococcus aureus containing cutaneous abscesses of HIV patients. Am J Emerg Med 2009; 27: 344-347.
37. Srinivasan A, Seifried S, Zhu L etal. Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. AIDS Res Hum Retroviruses 2009; 25: 1219-1224.
38. Hidron AI, Moanna A, Rimland D. The rise and fall of MRSA infections in HIV patients. AIDS 2011; 25: 1001-1003.
39. Klein E, Smith DL, Laxminarayan R. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg Infect Dis 2009; 15: 1925-1930.
40. Crum-Cianflone NF, Grandits G, Echols S etal. Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? J Acquir Immune Defic Syndr 2010; 54: 248-257.
41. Olsen RJ, Burns KM, Chen L etal. Severe necrotizing fasciitis in a human immunodeficiency virus-positive patient caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2008; 46: 1144-1147.
42. Miller LG, Perdreau-Remington F, Rieg G etal. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352: 1445-1453.
43. Vyas K, Hospenthal DR, Mende K etal. Recurrent community-acquired methicillin-resistant Staphylococcus aureus infections in an HIV-infected person. J Clin Microbiol 2011; 49: 2047-2053.
44. Sturgiss EA, Bowden FJ. Penile cellulitis due to community acquired methicillin-resistant Staphylococcus aureus in an HIV-positive man. Int J STD AIDS 2008; 19: 423-424.
45. Cook HA, Furuya EY, Larson E etal. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007; 44: 410-413.
46. Tsai HC, Chao PJ, Sy CL etal. Community-associated methicillin-resistant Staphylococcus aureus infective endocarditis with Panton-Valentine leukocidin gene in an injection drug user with HIV infection. Intern Med 2008; 47: 1485-1489.
47. Gebo KA, Burkey MD, Lucas GM etal. Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 2006; 43: 426-432.
48. Sayana S, Khanlou H. Meningitis due to hematogenous dissemination of community-associated methicillin-resistant Staphylococcus aureus (MRSA) in a patient with AIDS. J Int Assoc Physicians AIDS Care (Chic) 2008; 7: 289-291.
49. Kruse BT, Vadeboncoeur TF. Methicillin-resistant Staphylococcus aureus sepsis presenting with septic pulmonary emboli. J Emerg Med 2009; 37: 383-385.
50. Durão D, Fernandes AP, Marum S etal. Cardiac tamponade secondary to methicillin-resistant Staphylococcus aureus pericarditis. Rev Port Cardiol 2008; 27: 953-958.
51. Sayana S, Ricaurte JC, Khanlou H. An unusual pathogen for a liver abscess in a human immunodeficiency virus-infected individual. Am J Med Sci 2010; 339: 290-291.
52. Kempker R, Difrancesco L, Martin-Gorgojo A etal. Expanding spectrum of illness due to community-associated methicillin-resistant Staphylococcus aureus: a case report. Cases J 2009; 2: 7437.
53. Kempker RR, Farley MM, Ladson JL etal. Association of methicillin-resistant Staphylococcus aureus (MRSA) USA300 genotype with mortality in MRSA bacteremia. J Infect 2010; 61: 372-381.
54. Kallen AJ, Mu Y, Bulens S etal. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010; 304: 641-648.
55. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46: S344-S349.
56. Hsieh YH, Rothman RE, Bartlett JG etal. HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft-tissue infections. J Acquir Immune Defic Syndr 2008; 49: 398-405.
57. King MD, Humphrey BJ, Wang YF etal. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006; 144: 309-317.
58. McDougal LK, Steward CD, Killgore GE etal. Pulse-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41: 5113-5120.
59. Lina G, Piémont Y, Godail-Gamot F etal. Involvement of Panton-Valentine Leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-1132.
60. Gillet Y, Issartel B, Vanhems P etal. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
61. Naimi TS, LeDell KH, Como-Sabetti K etal. Comparison of community-associated and health-care associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-2984.
62. Gordon RJ, Quagliarello B, Cespedes C etal. A molecular epidemiological analysis of 2 Staphylococcus aureus clonal types colonizing and infecting patients with AIDS. Clin Infect Dis 2005; 40: 1028-1036.
63. Grim SA, Rapp RP, Martin CA etal. Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. Pharmacotherapy 2005; 25: 253-264.
64. Fridkin SK, Hageman JC, Morrison M etal. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352: 1436-1444.
65. Cosgrove SE, Sakoulas G, Perencevich EN etal. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59.
66. Centers for Disease Control and Prevention. Prevention of MRSA infections. Available at (accessed 20 March 2010).
67. Gordon RJ, Chez N, Jia H etal. The NOSE study (nasal ointment for Staphylococcus aureus eradication): a randomized controlled trial of monthly mupirocin in HIV-infected individuals. J Acquir Immune Defic Syndr 2010; 55: 466-472.